PSYKEY INC. | OTC : CEOS
PsyKey Inc. is vertically integrated in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations, for use in its premium quality functional product lines to help improve and optimize everyday life.
Psykey Inc. is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability, and targeted delivery of entheogenic based therapeutics for the fast-evolving psychedelic market.
Trading Symbols: CEOS (OTC PINK)
Market Cap: $27 000 000
Current Share Price: $0.13
Company website : https://psykeyworld.com/
PsyKey Inc. is currently in the development stages of patentable cutting-edge novel technologies, that will directly support and impact the fast-evolving therapeutic psilocybin market. These technologies are focused on composition, bioavailability, and targeted delivery.
PsyKey intends to submit two patent filings in Q2-Q3 2021, while the development and proof of concept continues on multiple other novel technologies.
PsyKey Product Line (Coming soon)
Psykey’s retail products include Functional Mushroom coffees and teas, oral supplements, and single serve drink mixes. All products are developed with premium quality ingredients and are designed to provide the best possible results for consumers. Our formulations are created utilizing functional mushrooms that have been used in traditional Chinese medicine and holistic healing for hundreds of years.
These mushrooms include: Reishi, Chaga, Lions Mane, Turkey Tail, Cordyceps, and Shiitake mushrooms. Coffee and tea products are manufactured by Cordoba Coffee with over 35 years of experience in the brewed beverage industry. Oral supplements and single serve drink mixes are manufactured by North American based GMP & site licensed manufacturing facilities.
Undervalue vs peers
June 01, 2021 | Why PSYKEY INC. is a huge opportunity in the psychedelic market ? | view here
May 20, 2021 | PsyKey Inc Announces Partnership with The Professional Gardener Co LTD to Develop and Distribute Innovative Products Designed for the Mushroom Production and Organic Farming Markets | view here
May 11, 2021 | PsyKey Inc Completes Definitive Agreement with MycoVita to establish a Strategic Partnership focused on Research, Development and Commercialization of Mycology based Products | view here
April 14, 2021 | PsyKey Inc. Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development | view here
March 29, 2021 | PsyKey Inc. Announces Former Royal Bank of Canada Managing Director to Head Advisory Board | view here
January 14, 2021 | Cecors, Inc. Shareholder Update | view here